Search details
1.
Decitabine in Older Patients with AML: Quality of Life Results of the EORTC-GIMEMA-GMDS-SG Randomized Phase III Trial.
Blood
; 2024 May 08.
Article
in English
| MEDLINE | ID: mdl-38717861
2.
Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long-term follow-up of the EORTC-GIMEMA randomized AML-10 trial.
Am J Hematol
; 99(3): 486-489, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38174977
3.
The prognostic value of IKZF1plus in B-cell progenitor acute lymphoblastic leukemia: Results from the EORTC 58951 trial.
Pediatr Blood Cancer
; 70(6): e30313, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36971444
4.
Quality of life of long-term childhood acute lymphoblastic leukemia survivors: Comparison with healthy controls.
Psychooncology
; 31(12): 2159-2168, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36307941
5.
Socio-economic outcomes among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study.
Eur J Cancer Care (Engl)
; 31(6): e13755, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36284405
6.
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(5): 643-654, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33857412
7.
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(5): 655-664, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33857414
8.
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
N Engl J Med
; 378(19): 1789-1801, 2018 May 10.
Article
in English
| MEDLINE | ID: mdl-29658430
9.
Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects study.
Hum Reprod
; 37(1): 44-53, 2021 12 27.
Article
in English
| MEDLINE | ID: mdl-34788455
10.
Long-term outcome evaluation of medium/high risk acute lymphoblastic leukaemia children treated with or without cranial radiotherapy in the EORTC 58832 randomized study.
Br J Haematol
; 189(2): 351-362, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31837008
11.
Pediatric randomized trial EORTC CLG 58951: Outcome for adolescent population with acute lymphoblastic leukemia.
Hematol Oncol
; 38(5): 763-772, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-32809224
12.
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long-term follow up of a phase III study.
Am J Hematol
; 95(7): 749-758, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32233095
13.
Results of successive EORTC-CLG 58 881 and 58 951 trials in paediatric T-cell acute lymphoblastic leukaemia (ALL).
Br J Haematol
; 186(5): 741-753, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31124581
14.
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
N Engl J Med
; 375(19): 1845-1855, 2016 11 10.
Article
in English
| MEDLINE | ID: mdl-27717298
15.
Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcome.
Haematologica
; 104(1): 59-69, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30171030
16.
Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype.
Haematologica
; 104(6): 1168-1175, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30523055
17.
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.
Ann Hematol
; 97(10): 1785-1795, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-29926156
18.
Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.
Lancet Oncol
; 18(3): 393-403, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28162999
19.
Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5-aza-2'-deoxycytidine (Decitabine).
Br J Haematol
; 176(4): 609-617, 2017 02.
Article
in English
| MEDLINE | ID: mdl-27905102
20.
Estimation of Distant Metastasis-free Survival in Trials of Adjuvant Therapy for Melanoma.
N Engl J Med
; 380(14): 1374-1376, 2019 04 04.
Article
in English
| MEDLINE | ID: mdl-30943345